Upcoming events on ASTELLAS PHARMA INC. |
|
01/29/21 | | Q3 2020 Pubblicazione dei risultati |
01/29/21 | 08:00am | | Q3 2020 Presentazione dei risultati |
03/30/21 | | Desprendimiento de dividendo final |
07/23/21 | | Q1 2021 Pubblicazione dei risultati (proiezione) |
|
Past events on ASTELLAS PHARMA INC. |
|
12/10/20 | 05:00am | | R&D Day |
12/06/20 | 07:30pm | | American Society of Hematology Meeting - Abstract #334 |
12/06/20 | 07:15pm | | American Society of Hematology Meeting - Abstract 333 |
12/05/20 | 09:00pm | | American Society of Hematology Meeting - Abstract #213 |
|
Upcoming sector events for ASTELLAS PHARMA INC. |
|
|
|
Past sector events for ASTELLAS PHARMA INC. |
|
|
|
Annual results | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 (e) |
Sales M JPY |
Released Forecast Spread | 1 372 706 1 389 912 -1,2% | 1 311 665 1 319 255 -0,58% | 1 300 316 1 295 193 0,40% | 1 306 348 1 300 930 0,42% | 1 300 843 1 274 827 2,0% | 1 269 281
|
Operating income (EBITDA) M JPY |
Released Forecast Spread | 337 887 313 439 7,8% | 324 621 331 297 -2,0% | 278 121 287 331 -3,2% | 307 370 320 763 -4,2% | 310 387 316 993 -2,1% | 304 771
|
Operating profit (EBIT) M JPY |
Released Forecast Spread | 268 699 241 562 11% | 260 830 271 929 -4,1% | 213 258 228 416 -6,6% | 243 912 261 093 -6,6% | 243 991 257 148 -5,1% | 231 884
|
Pre-Tax Profit (EBT) M JPY |
Released Forecast Spread | 261 770 252 112 3,8% | 281 769 278 738 1,1% | 218 113 230 652 -5,4% | 248 967 259 605 -4,1% | 245 350 262 926 -6,7% | 230 198
|
Net income M JPY |
Released Forecast Spread | 193 687 180 479 7,3% | 218 701 205 634 6,4% | 164 679 178 600 -7,8% | 222 265 215 115 3,3% | 195 411 203 519 -4,0% | 184 530
|
EPS JPY |
Released Forecast Spread | 89,8 83,4 7,7% | 104 97,9 5,9% | 81,1 89,5 -9,4% | 115 113 1,6% | 104 113 -7,8% | 101
| Announcement Date | 05/11/2016 | 04/27/2017 | 04/26/2018 | 04/25/2019 | 05/14/2020 | |
|
|
Quarterly results | 2016 S2 | 2017 S1 | 2018 S1 | 2018 S2 | 2019 Q1 | 2019 Q2 | 2019 S1 | 2019 Q3 | 2019 Q4 | 2019 S2 | 2020 Q1 | 2020 Q2 | 2020 S1 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 S1 | 2021 Q3 (e) | 2021 Q4 (e) | 2022 Q1 (e) | 2022 S1 (e) | 2023 S1 (e) |
Sales M |
Released Forecast Spread | 685 205
| 651 673 655 500 -0,58% | 639 754 633 500 0,99% | 660 562 653 200 1,1% | 329 085 318 313 3,4% | 318 011 326 974 -2,7% | 647 096 646 500 0,09% | 357 900 359 208 -0,36% | 301 320 311 288 -3,2% |
| 334 134 313 367 6,6% | 316 336 300 622 5,2% | 650 470 630 717 3,1% | 338 065 327 167 3,3% | 312 308 293 033 6,6% | 306 969 313 838 -2,2% | 308 511 317 330 -2,8% | 615 480 631 150 -2,5% | 327 175
| 320 285
| 314 000
| 631 000
| 643 000
|
Operating income (EBITDA) M |
Released Forecast Spread |
| 198 738
| 128 290
|
| 79 628 78 775 1,1% | 79 059 86 968 -9,1% |
| 98 400 98 767 -0,37% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit (EBIT) M JPY |
Released Forecast Spread |
| 157 057 163 000 -3,6% | 96 077 112 000 -14% | 117 181 109 250 7,3% | 63 548 65 717 -3,3% | 63 294 72 171 -12% | 126 842 131 500 -3,5% | 82 500 69 718 18% | 34 541 54 839 -37% |
| 77 086 67 500 14% | 85 110 60 293 41% | 162 196 135 036 20% | 75 462 64 475 17% | 6 333 35 700 -82% | 60 815 72 233 -16% | 26 057 69 070 -62% | 86 872 139 408 -38% | 72 300
| 56 800
| 66 000
| 130 500
| 131 000
|
Pre-Tax Profit (EBT) M JPY |
Released Forecast Spread |
| 157 772 164 500 -4,1% | 101 224 119 400 -15% | 116 889 109 300 6,9% | 64 495 66 163 -2,5% | 63 803 72 509 -12% | 128 298
| 84 500 69 909 21% | 36 139 55 100 -34% |
| 76 528 68 000 13% | 85 056 60 593 40% | 161 584 134 807 20% | 77 601 64 575 20% | 6 165 39 200 -84% | 60 238 72 033 -16% | 28 853 69 236 -58% | 89 091 139 808 -36% | 72 300
| 56 800
| 65 500
| 131 200
| 132 000
|
Net income M JPY |
Released Forecast Spread |
| 115 064 120 900 -4,8% | 82 117 92 400 -11% | 82 562 80 100 3,1% | 54 559 52 875 3,2% | 49 308 56 064 -12% | 103 867 106 000 -2,0% | 87 700 53 084 65% | 30 730 43 529 -29% |
| 58 518 53 533 9,3% | 70 009 47 593 47% | 128 527 105 652 22% | 61 494 52 900 16% | 5 390 30 600 -82% | 50 413 56 367 -11% | 22 425 54 652 -59% | 72 838 110 808 -34% | 56 400
| 44 300
| 52 000
| 104 200
| 105 000
|
EPS
|
Released Forecast Spread |
| 54,2 57,9 -6,5% | 40,0 45,8 -13% | 41,1 38,4 7,1% | 27,7 27,7 0,03% | 25,5 28,9 -12% | 53,2 51,1 4,1% | 45,4 29,9 52% | 16,4 22,7 -28% | 61,9
| 31,0 27,2 14% | 37,1 29,7 25% | 68,2 57,4 19% | 32,8 29,3 12% | 3,19 15,6 -80% | 27,1 29,3 -7,4% | 12,1 27,3 -56% | 39,2 54,5 -28% | 30,1
| 24,7
| 28,4
| 56,9
| 58,1
| Announcement Date | 05/11/2016 | 10/28/2016 | 10/31/2017 | 04/26/2018 | 07/27/2018 | 10/31/2018 | 10/31/2018 | 01/31/2019 | 04/25/2019 | 04/25/2019 | 07/30/2019 | 10/31/2019 | 10/31/2019 | 01/31/2020 | 05/14/2020 | 08/04/2020 | 10/30/2020 | 10/30/2020 | | | | | |
|
Financial data source © 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|